Our study demonstrated that BTZ plus THP presents a synergistically antitumor effect on T cell lymphoma cells and may be an optimal regimen in clinical trial of T cell lymphoma.
BTZ是一种很有前景的治疗T细胞淋巴瘤的靶向药物,为BTZ与THP联合治疗T细胞淋巴瘤的临床研究提供了实验依据。
Our study demonstrated that BTZ plus THP presents a synergistically antitumor effect on T cell lymphoma cells and may be an optimal regimen in clinical trial of T cell lymphoma.
BTZ是一种很有前景的治疗T细胞淋巴瘤的靶向药物,为BTZ与THP联合治疗T细胞淋巴瘤的临床研究提供了实验依据。
应用推荐